Imiquimod and Superficial Skin Cancers

September 2005 | Volume 4 | Issue 5 | Original Article | 598 | Copyright © September 2005

Mark Naylor MD

Topical imiquimod has opened an entirely new area of dermatology that previously did not exist: medical therapy for skin cancers. While surgery will continue to play a vital role in treating more aggressive tumors and in patients who may not be imiquimod candidates, the availability of a viable medical therapy that can be used independently or in combination with other modalities will considerably enhance our ability to treat skin cancer successfully.